Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MORF Morphic > Detailed Quotes

MORF Morphic

25.240
-0.740-2.85%
Close 09/26 16:00 ET
High
26.580
Open
25.950
Turnover
6.20M
Low
25.080
Pre Close
25.980
Volume
242.92K
Market Cap
971.16M
P/E(TTM)
Loss
52wk High
68.750
Shares
38.48M
P/E(Static)
Loss
52wk Low
19.230
Float Cap
649.53M
Bid/Ask %
100.00%
Historical High
93.000
Shs Float
25.73M
Volume Ratio
0.74
Historical Low
9.900
Dividend TTM
--
Div Yield TTM
--
P/B
2.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.94%
Amplitude
5.77%
Avg Price
25.537
Lot Size
1
Float Cap
649.53M
Bid/Ask %
100.00%
Historical High
93.000
Shs Float
25.73M
Volume Ratio
0.74
Historical Low
9.900
Dividend TTM
--
P/B
2.50
Dividend LFY
--
Turnover Ratio
0.94%
Amplitude
5.77%
Avg Price
25.537
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
CEO: Dr. Praveen P. Tipirneni, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...